CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Glycemic control is a mainstay of diabetes management to reduce the risk of microvascular complications and cardiovascular outcomes in peopl...
Seoul, Korea, Republic of and 1 other location
IV clinical study evaluating the efficacy and safety of switching Metformin+SGLT2-i+DPP4-i to Metformin+SGLT2-i+TZD in patients with type 2 diabetes...
Phase 4
Seoul, Seocho District, Korea, Republic of
glucose monitoring system (CGM) \[Freestyle Libre\] for a long period of time compared to self monitoring blood glucose(SMBG) in gestational diabetes...
Seoul, Korea, Republic of
To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...
Incheon, Korea, Republic of and 89 other locations
This is a randomized controlled study to assess the effect of choline fenofibrate compared with policosanol in Korean T2DM patients with asymptomatic...
Phase 4
Seongnam, Gyeonggi, Korea, Republic of
This is a randomized controlled study to assess the effect of atorvastatin and omega 3 combination therapy compared with atorvastatin and ezetimibe c...
Phase 4
Seongnam, Gyeonggi, Korea, Republic of
This study is to evaluating the impact of low-intensity statin plus ezetimibe versus high-intensity statin therapy on risk of new-onset diabetes...
Seoul, Korea, Republic of and 22 other locations
of this study is to evaluate safety and efficacy of ATB-1011 and ATB-1012 co-administration in patients with essential hypertension and type II diabetes...
Phase 3
Seongnam, Gyeonggi, Korea, Republic of
in improving hepatic and metabolic outcomes in patients with type 2 diabetes mellitus and metabolic dysfunction-associated fatty liver disea...
Phase 4
Seongnam-si, Korea, Republic of
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of and 648 other locations
Clinical trials
Research sites
Resources
Legal